Juno Bio is a biotechnology startup based in the United Kingdom, founded in 2018. The company is on a mission to decode the vaginal microbiome to close the gender health gap. Their efforts have garnered support from Illumina, a renowned name in the industry. The latest investment, a Convertible Note investment, took place on 18 August 2020 and was led by Acequia Capital. With its innovative approach and backing from industry leaders, Juno Bio is poised to make a significant impact in the field of women's health and biotechnology.
Juno Bio
Juno Bio is the world's first and fastest vaginal microbiome testing company.
Founded 2018
London, United States
6 employees
Seed
Total: $3.80M
Biotechnology, Life Sciences +2
London, United States
6 employees
Seed
Total: $3.80M
Biotechnology, Life Sciences +2
General Information
Get notified when Juno Bio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Juno Bio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Juno Bio
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed | •••••• | 4 |
|
16 Jul 2026 |
| Convertible Note | •••••• | 1 | •••• •••• | 18 Aug 2020 |
| Seed Round | •••••• | 2 |
|
01 Jan 2020 |
Latest News
View All
FAQ About Juno Bio
Juno Bio is the world's first and fastest vaginal microbiome testing company.
Juno Bio was founded in 2018.
Juno Bio is headquartered in London, United States.
Juno Bio operates in the following industries: Biotechnology, Life Sciences, Clean Energy, Machine Learning.
Juno Bio has approximately 6 employees.
Juno Bio has completed 3 funding rounds, raising a total of $3.80M. The latest funding stage is Seed.
Don't just browse. Track.
Signal Tracker monitors Juno Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.